Nomination Summary for Tetrahydroaminoacridine (THA) (N87101)

Nominated Substances: 1,2,3,4-Tetrahydro-9-acridinamine

Nomination Date: 09/21/1987

Nominator: NIEHS

Rationale: Tetrajudrpa,ompacrodome (THA) is an anticholinesterase agent which is currently being tested in a clinical trial for its efficacy in the treatment of Alzheimer's disease. No data on the chronic toxicity of THA in animals or humans.

NTP Principles: not specified

Status: No Testing


Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.


CASRN: 321-64-2

Agent Name: 1,2,3,4-Tetrahydro-9-acridinamine

  • No studies are available.